United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016)
United Therapeutics (UTHR) posted Amortizatization of Intangibles of -$100000.0 for Q2 2016, up 50.0% sequentially from -$200000.0 in Q1 2016, and up 75.0% YoY from -$57142.9 in Q3 2015.
United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016) Analysis & Trends
United Therapeutics has reported Amortizatization of Intangibles for 8 years, with the latest figure at -$100000.0 in Q2 2016.
- Quarterly Amortizatization of Intangibles rose 75.0% year-over-year to -$100000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was -$1.0 million (up 71.67% YoY) and the FY2015 annual result came in at -$2.1 million, up 59.24% from the prior year.
- Amortizatization of Intangibles climbed to -$100000.0 in Q2 2016 per UTHR's latest filing, from -$200000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at -$100000.0 in Q2 2016 and troughed at -$1.6 million in Q1 2014.
- A 5-year average of -$931555.6 and a median of -$1.0 million in 2013 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2014 and 2016: Amortizatization of Intangibles tumbled 59.44% in 2014, then surged 80.0% in 2016.
- Over 5 years, Amortizatization of Intangibles stood at -$1.3 million in 2012, then retreated by 10.3% to -$1.4 million in 2013, then gained by 27.8% to -$1.0 million in 2014, then soared by 74.32% to -$266000.0 in 2015, then surged by 62.41% to -$100000.0 in 2016.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$100000.0, -$200000.0, and -$266000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.34 Bn | 39.68 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.16 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.74 Bn | 22.95 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.83 Bn | 17.94 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.73 Bn | 15.34 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.15 Bn | 11.62 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.18 Bn | 10.02 Bn | - | - |
| 10 | Alkermes | 8.23 Bn | 7.58 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -100,000.00 |
| Jun 30, 2016 | -100,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Mar 31, 2015 | -1.00 Mn |
| Mar 31, 2015 | -1.00 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Mar 31, 2014 | -1.60 Mn |
| Mar 31, 2014 | -1.60 Mn |